Literature DB >> 16271518

The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro.

M Ramos1, M W Lamé, H J Segall, D W Wilson.   

Abstract

Polymorphic mutations in the Bone Morphogenetic Protein type II receptor (BMPrII) gene have been implicated in the development of familial primary pulmonary hypertension (PPH) however, the role BMPrII mutations play in the development of PH has not yet been elucidated. Endothelial caveolae are an important domain of hemodynamics containing eNOS, the serotonin transporter, and endothelin receptors. In this study we show by standard immunohistochemistry (IHC) that BMPrII is widely distributed in the vasculature of the rat lung, and more specifically distributed to both apical and basal membranes of the arteriolar endothelium by fluorescent IHC. We also examined compartmentalization of BMPrII in lipid fractions of plasma membranes isolated by silica based extraction from human pulmonary artery endothelial cells and rat lung endothelium. Density gradient centrifugation demonstrated BMPrII in separate caveolin-1 (cav-1) and non-cav-1 lipid rich fractions. Electron microscopy co-localized cav-1 and BMPrII in flask shaped membrane fragments. Three-dimensional fluorescence microscopy demonstrated BMPrII in discrete membrane foci, a portion of which were co-localized with cav-1, as well as in Golgi. Our findings indicate that BMPrII is located within lipid-dense fractions of pulmonary endothelial cell membranes with a portion present in caveolae suggesting potential dynamic regulatory structural relationships.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271518     DOI: 10.1016/j.vph.2005.09.007

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  28 in total

1.  Initiation of BMP2 signaling in domains on the plasma membrane.

Authors:  Jeremy Bonor; Elizabeth L Adams; Beth Bragdon; Oleksandra Moseychuk; Kirk J Czymmek; Anja Nohe
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

Review 2.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

3.  Abnormal expression of NSF, α-SNAP and SNAP23 in pulmonary arterial hypertension in rats treated with monocrotaline.

Authors:  Hong-Liang Zhang; Zhi-Hong Liu; Qin Luo; Yong Wang; Zhi-Hui Zhao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-β-driven pulmonary vascular remodeling.

Authors:  Suellen D S Oliveira; Maricela Castellon; Jiwang Chen; Marcelo G Bonini; Xiaowu Gu; Michael H Elliott; Roberto F Machado; Richard D Minshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-10       Impact factor: 5.464

5.  Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation.

Authors:  Archana Gangopahyay; Max Oran; Eileen M Bauer; Jeffrey W Wertz; Suzy A Comhair; Serpil C Erzurum; Philip M Bauer
Journal:  J Biol Chem       Date:  2011-08-01       Impact factor: 5.157

Review 6.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

7.  Hereditary spastic paraplegia-causing mutations in atlastin-1 interfere with BMPRII trafficking.

Authors:  Jiali Zhao; Peter Hedera
Journal:  Mol Cell Neurosci       Date:  2012-10-16       Impact factor: 4.314

8.  S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4.

Authors:  Edda Spiekerkoetter; Christophe Guignabert; Vinicio de Jesus Perez; Tero-Pekka Alastalo; Janine M Powers; Lingli Wang; Allan Lawrie; Noona Ambartsumian; Ann-Marie Schmidt; Mark Berryman; Richard H Ashley; Marlene Rabinovitch
Journal:  Circ Res       Date:  2009-08-27       Impact factor: 17.367

9.  Caveolin-1 Expression and Hemodynamics in COPD Patients.

Authors:  Lars C Huber; Alex Soltermann; Manuel Fischler; Steffen Gay; Walter Weder; Erich W Russi; Rudolf Speich; Silvia Ulrich
Journal:  Open Respir Med J       Date:  2009-05-13

10.  Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries.

Authors:  Stefano Cagnin; Michele Biscuola; Cristina Patuzzo; Elisabetta Trabetti; Alessandra Pasquali; Paolo Laveder; Giuseppe Faggian; Mauro Iafrancesco; Alessandro Mazzucco; Pier Franco Pignatti; Gerolamo Lanfranchi
Journal:  BMC Genomics       Date:  2009-01-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.